Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art

M De Bonis; O Alfieri; M Dalrymple-Hay; B Del Forno; F Dulguerov; G Dreyfus

doi:10.1016/j.pcad.2017.10.006

Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art

M De Bonis, O Alfieri, M Dalrymple-Hay, B Del Forno, F Dulguerov, G Dreyfus

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. © 2017 Elsevier Inc.

Original language	English
Pages (from-to)	386-393
Number of pages	8
Journal	Progress in Cardiovascular Diseases
Volume	60
Issue number	3
DOIs	https://doi.org/10.1016/j.pcad.2017.10.006
Publication status	Published - 2017

Access to Document

10.1016/j.pcad.2017.10.006

http://www.scopus.com/inward/record.url?scp=85036566944&partnerID=8YFLogxK

Fingerprint Dive into the research topics of 'Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art'. Together they form a unique fingerprint.

Cite this

@article{6f4dcbeaa8a747c0930cd2a409b3d09d,

title = "Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art",

abstract = "In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. {\textcopyright} 2017 Elsevier Inc.",

author = "{De Bonis}, M and O Alfieri and M Dalrymple-Hay and {Del Forno}, B and F Dulguerov and G Dreyfus",

year = "2017",

doi = "10.1016/j.pcad.2017.10.006",

language = "English",

volume = "60",

pages = "386--393",

journal = "Progress in Cardiovascular Diseases",

issn = "0033-0620",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art

AU - De Bonis, M

AU - Alfieri, O

AU - Dalrymple-Hay, M

AU - Del Forno, B

AU - Dulguerov, F

AU - Dreyfus, G

PY - 2017

Y1 - 2017

N2 - In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. © 2017 Elsevier Inc.

AB - In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. © 2017 Elsevier Inc.

U2 - 10.1016/j.pcad.2017.10.006

DO - 10.1016/j.pcad.2017.10.006

M3 - Article

VL - 60

SP - 386

EP - 393

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 3

ER -